NUDT1 and glioblastoma: As the cellular fraction depleted for CD133 did not form stable intracranial tumors, likely due to the absence of stem cells, we followed additionally a non-orthotopic implantation approach to show that inhibition of MTH1 targets both GBM as well as GSCs (see Supplementary Figure S12).